rs13254738

Variant summary

Our verdict is . The variant received -12 ACMG points: 0P and 12B. BA1BP4_Strong

The NR_109833.1(PRNCR1):n.12225C>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.562 (AC=87,206) in the gnomAD database across 155,062 control chromosomes, including 26,115 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.676. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.56 ( 25535 hom., cov: 31)
Exomes 𝑓: 0.60 ( 580 hom. )

Consequence

PRNCR1
NR_109833.1 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.280

Publications

82 publications found
Variant links:
Genes affected
PRNCR1 (HGNC:48942): (prostate cancer associated non-coding RNA 1)
CASC19 (HGNC:49476): (cancer susceptibility 19)
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NR_109833.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available.; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6760 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

ACMG analysis was done for transcript: NR_109833.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRNCR1
NR_109833.1
n.12225C>A
non_coding_transcript_exon
Exon 1 of 1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRNCR1
ENST00000635449.1
TSL:6
n.12225C>A
non_coding_transcript_exon
Exon 1 of 1
CASC19
ENST00000642100.1
n.418-12965G>T
intron
N/A
PCAT1
ENST00000645463.1
n.855+85480C>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.562
AC:
85329
AN:
151810
Hom.:
25545
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.378
Gnomad AMI
AF:
0.784
Gnomad AMR
AF:
0.506
Gnomad ASJ
AF:
0.595
Gnomad EAS
AF:
0.307
Gnomad SAS
AF:
0.638
Gnomad FIN
AF:
0.648
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.681
Gnomad OTH
AF:
0.585
GnomAD4 exome
AF:
0.599
AC:
1877
AN:
3134
Hom.:
580
Cov.:
0
AF XY:
0.602
AC XY:
1001
AN XY:
1664
show subpopulations
African (AFR)
AF:
0.422
AC:
27
AN:
64
American (AMR)
AF:
0.500
AC:
25
AN:
50
Ashkenazi Jewish (ASJ)
AF:
0.558
AC:
48
AN:
86
East Asian (EAS)
AF:
0.367
AC:
171
AN:
466
South Asian (SAS)
AF:
0.600
AC:
24
AN:
40
European-Finnish (FIN)
AF:
0.656
AC:
252
AN:
384
Middle Eastern (MID)
AF:
0.636
AC:
14
AN:
22
European-Non Finnish (NFE)
AF:
0.651
AC:
1231
AN:
1890
Other (OTH)
AF:
0.644
AC:
85
AN:
132
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
36
72
109
145
181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.562
AC:
85329
AN:
151928
Hom.:
25535
Cov.:
31
AF XY:
0.559
AC XY:
41513
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.378
AC:
15647
AN:
41392
American (AMR)
AF:
0.505
AC:
7719
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.595
AC:
2063
AN:
3468
East Asian (EAS)
AF:
0.308
AC:
1590
AN:
5166
South Asian (SAS)
AF:
0.638
AC:
3075
AN:
4820
European-Finnish (FIN)
AF:
0.648
AC:
6827
AN:
10534
Middle Eastern (MID)
AF:
0.585
AC:
172
AN:
294
European-Non Finnish (NFE)
AF:
0.681
AC:
46293
AN:
67956
Other (OTH)
AF:
0.582
AC:
1228
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1775
3551
5326
7102
8877
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.620
Hom.:
53440
Bravo
AF:
0.539
Asia WGS
AF:
0.449
AC:
1559
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.378
AC:
46317
AN:
122670
Turkish Variome
AF:
0.684
AC:
1058
AN:
1546
Hom.:
360
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.276
AC:
2472
AN:
8960
Hom.:
361
ABraOM SABE-WGS-1171
AF:
0.560
AC:
1311
AN:
2342
Hom.:
395

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.86
DANN
Benign
0.50
PhyloP100
0.28

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.